Duality Biologics
DualityBio is a clinical stage company focusing on the discovery and development of the next generation ADC therapeutics to treat patients in cancer and autoimmune diseases.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD556—835m (Dealroom.co estimates May 2021.)
Shanghai Shanghai (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
N/A | Series A | ||
$90.0m | Series B | ||
| Total Funding | AUD139m | ||